Cannabinoid treatment for autism: a proof-of-concept randomized trial

被引：0
|
作者：
Adi Aran
Moria Harel
Hanoch Cassuto
Lola Polyansky
Aviad Schnapp
Nadia Wattad
Dorit Shmueli
Daphna Golan
F. Xavier Castellanos
机构：
[1] Shaare Zedek Medical Center,Neuropediatric Unit
[2] Clalit Health Services,Child Development Centers
[3] Maccabi Health Services,Child Development Centers
[4] NYU Grossman School of Medicine,Department of Child and Adolescent Psychiatry
来源：
Molecular Autism | / 12卷
关键词：
Autism spectrum disorder; Cannabinoids; Cannabidiol; Tetrahydrocannabinol; Clinical trials randomized controlled; Neuropsychology; Behavior; Child psychiatry; Developmental disorders; Entourage effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
    Nagele, Peter
    Duma, Andreas
    Kopec, Michael
    Gebara, Marie Anne
    Parsoei, Alireza
    Walker, Marie
    Janski, Alvin
    Panagopoulos, Vassilis N.
    Cristancho, Pilar
    Miller, J. Philip
    Zorumski, Charles F.
    Conway, Charles R.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 78 (01) : 10 - 18
  • [42] BRIEF COGNITIVE-BEHAVIORAL TREATMENT FOR GASTROPARESIS: A PROOF-OF-CONCEPT OPEN TRIAL
    Abber, Sophie R.
    Edwards, Robert
    Napadow, Vitaly
    Konkel, Hannah
    Juarascio, Adrienne
    Kuo, Braden
    Murray, Helen Burton
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S248 - S248
  • [43] A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI)
    Wathen, J. Kyle
    Jagannatha, Shyla
    Ness, Seth
    Bangerter, Abigail
    Pandina, Gahan
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 32
  • [44] Treatment of erythropoietic protoporphyria with the oral sorbent colestipol: A proof-of-concept clinical trial
    Tishler, Peter V.
    Rosner, Bernard
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) : 391 - 392
  • [45] US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
    Finberg, Robert W.
    Ashraf, Madiha
    Julg, Boris
    Ayoade, Folusakin
    Marathe, Jai G.
    Issa, Nicolas C.
    Wang, Jennifer P.
    Jaijakul, Siraya
    Baden, Lindsey R.
    Epstein, Carol
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
  • [46] Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia
    Olincy, Ann
    Harris, Josette G.
    Johnson, Lynn L.
    Pender, Vicki
    Kongs, Susan
    Allensworth, Diana
    Ellis, Jamey
    Zerbe, Gary O.
    Leonard, Sherry
    Stevens, Karen E.
    Stevens, James O.
    Martin, Laura
    Adler, Lawrence E.
    Soti, Ferenc
    Kem, William R.
    Freedman, Robert
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (06) : 630 - 638
  • [47] Buzz around Campath proof-of-concept trial in MS
    Randy Osborne
    [J]. Nature Biotechnology, 2009, 27 : 6 - 8
  • [48] The Evaluation of Proof-of-Concept Trial Design for Compound Selection
    Lu, Jiandong
    Dong, Bin
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (04): : 315 - 320
  • [49] Proof-of-concept trial for 'AZ modification' of supraglottic airways
    Avitsian, R.
    Zura, A.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2018, 121 (01) : E5 - E5
  • [50] Buzz around Campath proof-of-concept trial in MS
    Osborne, Randy
    [J]. NATURE BIOTECHNOLOGY, 2009, 27 (01) : 6 - 8
12345